Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Case report on CoreFlow Soft Stent® published

ProstaLund

In Mega Journal of Case Reports a case report on ProstaLund's CoreFlow Soft Stent has been published.

Dr. Sonny Schelin has got a case report, ”CoreFlow Soft Stent® used as a Persistent Catheter Substitute for 11 Months Waiting for Surgery: Spontaneous Micturition and Full Continence” published in the journal Mega Journal of Case Reports.

The report describes a patient with urinary retention, caused by benign prostatic hyperplasia, who, while waiting for surgical treatment during the pandemic years, used 11 CoreFlow instead of indwelling urinary catheters.

With the help of CoreFlow, the patient was symptom-free, satisfied and emptied the bladder spontaneously for almost a year with the help of the stents that remedied the obstruction through the prostate. Not a single episode of urinary retention or urinary tract infection was recorded during the stent period.

Schelin concludes in the report that CoreFlow can eliminate the discomfort of indwelling catheters and reduce the risk of urinary tract infections for patients waiting for active treatment.

"CoreFlow is a fantastic alternative to all men with urinary retention who want to avoid an indwelling catheter. I am happy together with every patient who is given this opportunity.", says CEO Johan Wennerholm in a comment.

https://megajournalofcasereports.com/wp-content/uploads/2023/05/MJCR-6-2105.pdf

For further information, please contact:


Johan Wennerholm,  CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com

About ProstaLund


ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

Attachments


Case report on CoreFlow Soft Stent® published

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team